NCT05177744
- Conditions
- Asthma in Children, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +16 more
- Locations
-
- Children's Hospital Srebrnjak Zagreb, City of Zagreb, Croatia
Clinical trial condition
Dermatitis
Explore clinical trials studying Dermatitis. Study availability and eligibility vary by location and protocol.
1,525 public trials
180 recruiting studies
Dermatitis trial results
Completed
Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis
NCT05844618
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Innovaderm Research Inc. Montreal, Quebec, Canada
NCT06492902
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- University of Medical Center HCMC - Branch no.3 Ho Chi Minh City, Vietnam
- Traditional Medicine Hospital of Ho Chi Minh City Ho Chi Minh City, Vietnam
NCT05650320
- Conditions
- Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Beijing Children's Hospital, Capital Medical University Beijing, Beijing Municipality, China
NCT03858634
- Conditions
- Chronic Disease, Chronic Idiopathic Pruritus, Chronic Idiopathic Urticaria, +22 more
- Locations
-
- Site 106 Anniston, Alabama, United States
- Site 110 Phoenix, Arizona, United States
- Site 114 Hot Springs, Arkansas, United States
- Site 103 Los Angeles, California, United States
NCT04173247
- Conditions
- Dermatitis, Head and Neck Cancer, Head and Neck Neoplasms, +8 more
- Locations
-
- Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
NCT06723340
- Conditions
- Dermatitis, Dermatitis, Contact, Dermatitis, Irritant, +8 more
- Locations
-
- Medcin Instituto da Pele Ltda Osasco, São Paulo, Brazil
NCT04922021
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- LEO Pharma Investigational Site Birmingham, Alabama, United States
- LEO Pharma Investigational Site Fountain Valley, California, United States
- LEO Pharma Investigational Site Los Angeles, California, United States
- LEO Pharma Investigational Site Doral, Florida, United States
Completed
A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT06058000
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- The First Hospital of China Medical University Shenyang, Liaoning, China
- Dermatology Hospital of Shandong First Medical University Jinan, Shandong, China
NCT03725722
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Leo Pharma Investigational Site Birmingham, Alabama, United States
- Leo Pharma Investigational Site Encino, California, United States
- Leo Pharma Investigational Site Los Angeles, California, United States
- Leo Pharma Investigational Site Los Angeles, California, United States